ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,070.55
1.20%
US Tech 100
17,095.60
2.05%
Dow Jones
38,503.69
0.69%
Brent Oil
87.695
0.15%
Bitcoin
66,779.08
0.55%
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Celldex Therapeutics Inc (CLDX) Quote

Celldex Therapeutics Inc

Celldex Therapeutics Inc (CLDX)

NASDAQ
37.77
-1.08
(-2.78%)
Closed April 24 4:00PM
Delayed by 15 minutes
38.00
0.23
(0.61%)
After Hours: 7:47PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
38.00
Bid
36.56
Ask
39.18
Volume
435,996
37.62 Day's Range 39.67
22.11 52 Week Range 53.18
Market Cap
2.11B
Previous Close
38.85
Open
38.91
Last Trade
100
@
38
(formt)
Last Trade Time
Financial Volume
$ 16,876,333
VWAP
38.7075
Average Volume (3m)
964,123
Shares Outstanding
55,900,679
Dividend Yield
-
PE Ratio
-14.92
Earnings Per Share (EPS)
-2.53
Revenue
6.88M
Net Profit
-141.43M

About Celldex Therapeutics Inc

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung c... Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527. Show more

Sector
In Vitro,in Vivo Diagnostics
Industry
In Vitro,in Vivo Diagnostics
Website
www.celldex.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Celldex Therapeutics Inc is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker CLDX. The last closing price for Celldex Therapeutics was $38.85. Over the last year, Celldex Therapeutics shares have traded in a share price range of $ 22.11 to $ 53.18.

Celldex Therapeutics currently has 55,900,679 shares outstanding. The market capitalization of Celldex Therapeutics is $2.11 billion. Celldex Therapeutics has a price to earnings ratio (PE ratio) of -14.92.

CLDX Latest News

More News

Celldex Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria

HAMPTON, N.J., April 17, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that patient enrollment has been completed in the Company’s Phase 2 clinical study of...

April 17 2024
GlobeNewswire Inc.

Celldex Therapeutics to Participate in the Leerink Partners Global Biopharma Conference

HAMPTON, N.J., March 08, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in a fireside chat at the Leerink Partners Global...

March 08 2024
GlobeNewswire Inc.

Celldex Therapeutics to Present at TD Cowen’s 44th Annual Health Care Conference

HAMPTON, N.J., March 05, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that Anthony S. Marucci, President and Chief Executive Officer will participate in an...

March 05 2024
GlobeNewswire Inc.

Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

HAMPTON, N.J., March 05, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced the closing of its previously announced underwritten...

March 05 2024
GlobeNewswire Inc.

Form 8-K - Current report

March 01 2024
Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]

March 01 2024
Edgar (US Regulatory)

Celldex Therapeutics Announces Pricing of Upsized $400 Million Public Offering of Common Stock

HAMPTON, N.J., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced the pricing of an upsized underwritten public offering of...

February 29 2024
GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]

February 28 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.03-2.6389956443839.0340.4536.7867982138.81004308CS
4-3.64-8.7415946205641.6442.3836.7862727240.01883195CS
121.764.8565121412836.2453.1834.6596412343.29077075CS
261246.15384615382653.1822.1188618737.74966988CS
521.494.0810736784436.5153.1822.1167261735.6352181CS
15611.1541.527001862226.8557.219.8562695635.71108986CS
26034.34938.251366123.6657.21.568214624.44727463CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NIVFNewGenIvf Group Ltd
$ 2.23
(74.22%)
137.08M
MTCMMTec Inc
$ 2.24
(43.59%)
6.07M
OPRTOportun Financial Corporation
$ 3.16
(40.44%)
11.71M
SHIMShimmick Corporation
$ 3.05
(35.56%)
1.19M
HKITHitek Global Inc
$ 1.35
(32.35%)
411.78k
ABEOAbeona Therapeutics Inc
$ 3.39
(-53.94%)
5.51M
GWAVGreenwave Technology Solutions Inc
$ 0.0696
(-44.89%)
37.05M
LICNLichen China Limited
$ 0.56
(-42.19%)
6.61M
MLECMoolec Science SA
$ 1.71
(-30.77%)
3.16M
VAXXVaxxinity Inc
$ 0.1971
(-26.89%)
2.11M
CYNCYNGN Inc
$ 0.113
(-6.61%)
326.58M
PEGYPineapple Energy Inc
$ 0.0561
(22.49%)
185.74M
SQQQProShares UltraPro Short QQQ
$ 11.91
(-4.49%)
139.15M
NIVFNewGenIvf Group Ltd
$ 2.23
(74.22%)
137.08M
TSLATesla Inc
$ 144.68
(1.85%)
124.55M

CLDX Discussion

View Posts
harry crumb harry crumb 2 months ago
Indeed
👍️0
Monksdream Monksdream 2 months ago
CLDX new 52 week high
👍️0
harry crumb harry crumb 2 months ago
We shorted the offering for 2 days, in an out then long since
👍️0
Monksdream Monksdream 2 months ago
CLDX new 52 week high
👍️0
harry crumb harry crumb 2 months ago
That was way back, we went long but are out. Missed this pop
👍️0
fwb fwb 2 months ago
Did you SHORT CLDX back in NOV 2023?
If you did you loss your PANTS (SHORTS)
👍️0
harry crumb harry crumb 6 months ago
Burn cldx burn, another round of dilution, shorting this is money!
👍️0
harry crumb harry crumb 6 months ago
Timber lmao
👍️0
harry crumb harry crumb 6 months ago
Tomorrow this will be 24
👍️0
harry crumb harry crumb 6 months ago
Sold out the pump thank god. Short position now after this news of dilution, this company sure knows how to screw long investors. 25k short, lets take it to 20 now folks
👍️0
harry crumb harry crumb 6 months ago
Told everybody shorts are an still are in deep risk moving forward. Looking at a run to 44+ coming
👍️0
harry crumb harry crumb 6 months ago
Cldx will be bought out in due time imo $$$$$$$$ shorts continue to burn to ground
👍️0
harry crumb harry crumb 6 months ago
Burn shorts burn, this is going to be epic when it happens, buyout can happen anytime! $$$$$
👍️0
harry crumb harry crumb 6 months ago
I can’t wait to see the naked shorts fry like pigs when the buyout price is announced!40+ $$$$$!
👍️0
harry crumb harry crumb 7 months ago
Buying more
👍️0
harry crumb harry crumb 7 months ago
Buy it up shorts are gonna pay deeply, buyout ahead imo. $$$$$$
👍️0
harry crumb harry crumb 8 months ago
Loading again here
👍️0
harry crumb harry crumb 8 months ago
Buying opportunity, bought the dip at open, looking real good
👍️0
fwb fwb 1 year ago
COULD BE.
👍️0
harry crumb harry crumb 1 year ago
Could be a buyout coming
👍️0
harry crumb harry crumb 1 year ago
Another positive for cldx $$$$
👍️0
fwb fwb 1 year ago
This stock use to be called Avant Immunotherapeutics

Avant Immunotherapeutics to Merge with Celldex Therapeutics, Inc. in All-Stock Deal
👍️0
harry crumb harry crumb 1 year ago
Hey mr canes, how u been, gl this year
👍️0
harry crumb harry crumb 1 year ago
More wealth with this play, question is, what is brewing here, not many followers but flipping this has been easy money, all free shares here riding it onward for some epic news
👍️0
harry crumb harry crumb 1 year ago
Lmao, your alright. GL
👍️0
The Canes The Canes 1 year ago
Based on your imbecilic remarks I implore you seek counseling. Pointedly seek juvenile counseling. Now please go back to posting to yourself. I'm taking to my wife out to our favorite Michelin spot and a enjoying bottle of Dom Perignon. The 2003 Plenitude - 2 is special. Of course since you can't afford it you'll have to take my word for it. Have a cold Busch instead it's as close as you'll come to a woman. Get well!
👍️0
harry crumb harry crumb 1 year ago
Dont forget to put your dolls away, barbie might get mad at you.
👍️0
harry crumb harry crumb 1 year ago
Yur wife luvs me! Lmao little guy
👍️0
The Canes The Canes 1 year ago
You're making me laugh...you made my morning! By the way I bought Celldex way before you and your fantasy group. Go back to posting gibberish with someone else. I'm busy raking in money shorting your minuscule positions. You're the king...of clowns on IHUB.
👍️0
harry crumb harry crumb 1 year ago
Yo brainless, if you would hav bought this when we did in the 20’s you would be thanking me like the rest of my group is now, a true double so go get lost under a rock an learn how to invest an become a real investor like i am. You will never het rich pal, lmao
👍️0
harry crumb harry crumb 1 year ago
Is there anyone else into cldx on here, what a run in last 3 weeks!$$$$
👍️0
harry crumb harry crumb 1 year ago
Another ride up here
👍️0
harry crumb harry crumb 1 year ago
19.6% green today. Wow
👍️0
harry crumb harry crumb 1 year ago
Wow, nice gains today $$$
👍️0
harry crumb harry crumb 2 years ago
Nobody here? This just keeps popping
👍️0
harry crumb harry crumb 2 years ago
A whale knows when a bio is on to something, cldx may finally hit it big! $$$
👍️0
harry crumb harry crumb 2 years ago
More good news an the stock gets hammered. Typical bio shorting. Could be a 100+ pps one day!
👍️0
harry crumb harry crumb 2 years ago
Whats the word on this freefall going on? Just shorts trying to leverage more out of it before it goes to 50+, word on the vine is they may have a huge winner coming
👍️0
harry crumb harry crumb 3 years ago
Something is going to be announced real soon, an its looking positive imo! $$$$
👍️0
make it happen make it happen 3 years ago
Don't forget the additional $26,500,000 million they can add.
👍️0
make it happen make it happen 3 years ago
Another $175,000,000 raised in dilution... Share price depletes
👍️0
make it happen make it happen 3 years ago
W.e. let one switch how they want, if something failed. I'd flip side as well lmao
👍️0
harry crumb harry crumb 3 years ago
Get lost, you got no clue who we are, lmao. If u did u would want in with us, trust me. We run stocks an avoid people like u
👍️0
The Canes The Canes 3 years ago
Crumb showed up on IDRA years ago. He was pounding the table for months telling everybody to buy it. He touted their amazing pipeline. Then they failed a Phase 3. The very next day he was short and said he had warned everyone to steer clear of the POS. He isn't a legitimate investor. If he was he wouldn't be killing time posting almost 10,000 times on IHUB. Legitimate investors invest they don't incessantly post rubbish.
👍️0
make it happen make it happen 3 years ago
2 R/S so far
👍️0
make it happen make it happen 3 years ago
Can trade in any direction and get burnt in any direction. Everyone trades differently.
👍️0
make it happen make it happen 3 years ago
Def make some either way you trade but the financials and beyond that. It's only going to get worse. It's only Phase 1b... Many phases to go 2 & 3 (a +b maybe)doubles time and phases again. That's only the phases with out going into specifics.
👍️0
The Canes The Canes 3 years ago
I have a great track record. I do the opposite of what you profess to be doing and it's been 100% successful LMAO!
👍️0
harry crumb harry crumb 3 years ago
Lmao, someday you might learn how to trade, GL
👍️0
harry crumb harry crumb 3 years ago
Great post! Truly 100% fact! Thats why we shorted it awhile back, made wealth! Currently, Possibility's are there for a reversal, whether short or long term, time will tell. We took a position before, prior to insiders buying an a hefty position when they bought. Looking like wealth again. Trading bio's is risky either way, long, short, options, etc., but if you trade them on the current state of the company's performance, an on future performance, it should lead you to which way to go. We do, an we make wealth... $$$$$
👍️0

Your Recent History

NASDAQ
CLDX
Celldex Therapeutics
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved